Total Payments
$331,146
2024 Payments
$49,244
Companies
43
Transactions
1,075
Medicare Patients
1,857
Medicare Billing
$1.5M
Payment Breakdown by Category
Other$202,823 (61.2%)
Research$81,107 (24.5%)
Food & Beverage$23,647 (7.1%)
Consulting$12,720 (3.8%)
Travel$10,779 (3.3%)
Education$70.31 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200,423 | 102 | 60.5% |
| Unspecified | $81,107 | 15 | 24.5% |
| Food and Beverage | $23,647 | 911 | 7.1% |
| Consulting Fee | $12,720 | 6 | 3.8% |
| Travel and Lodging | $10,779 | 33 | 3.3% |
| Honoraria | $2,400 | 2 | 0.7% |
| Education | $70.31 | 6 | 0.0% |
Payments by Type
General
$250,039
1,060 transactions
Research
$81,107
15 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $83,537 | 173 | $0 (2024) |
| GENZYME CORPORATION | $81,235 | 143 | $0 (2024) |
| SANOFI US SERVICES INC. | $81,107 | 15 | $0 (2019) |
| GlaxoSmithKline, LLC. | $44,254 | 156 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $16,102 | 183 | $0 (2024) |
| Circassia Pharmaceuticals Inc | $10,084 | 18 | $0 (2019) |
| ALK-Abello, Inc | $2,605 | 8 | $0 (2021) |
| Amgen Inc. | $2,506 | 7 | $0 (2024) |
| Dermavant Sciences, Inc. | $1,640 | 1 | $0 (2024) |
| PFIZER INC. | $1,125 | 56 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49,244 | 142 | GENZYME CORPORATION ($22,854) |
| 2023 | $28,087 | 123 | Regeneron Healthcare Solutions, Inc. ($13,453) |
| 2022 | $28,630 | 132 | Regeneron Healthcare Solutions, Inc. ($10,587) |
| 2021 | $39,954 | 127 | GlaxoSmithKline, LLC. ($14,593) |
| 2020 | $11,753 | 97 | Regeneron Healthcare Solutions, Inc. ($5,216) |
| 2019 | $29,913 | 169 | GENZYME CORPORATION ($10,214) |
| 2018 | $68,373 | 135 | SANOFI US SERVICES INC. ($45,194) |
| 2017 | $75,192 | 150 | SANOFI US SERVICES INC. ($27,379) |
All Payment Transactions
1,075 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Immunology and Neurology | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,932.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $119.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | ADMA BioManufacturing LLC | — | Consulting Fee | Cash or cash equivalent | $22.15 | General |
| 11/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $122.64 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $11.66 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,866.00 | General |
| Category: Immunology | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $104.49 | General |
| 10/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.42 | General |
| Category: Immunology | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.15 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Efficacy Asthma Pediatric | SANOFI US SERVICES INC. | $58,308 | 8 |
| Liberty Asthma | SANOFI US SERVICES INC. | $14,265 | 3 |
| One Year Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Pediatric Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study | SANOFI US SERVICES INC. | $4,684 | 3 |
| A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Children 6 to <12 Years of Age With Uncontrolled Persistent Asthma | SANOFI US SERVICES INC. | $3,850 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 523 | 19,621 | $801,334 | $347,817 |
| 2022 | 12 | 426 | 16,373 | $724,757 | $317,491 |
| 2021 | 11 | 478 | 21,057 | $924,825 | $410,906 |
| 2020 | 10 | 430 | 20,319 | $915,821 | $403,907 |
Total Patients
1,857
Total Services
77,370
Medicare Billing
$1.5M
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 17 | 9,058 | $569,835 | $272,876 | 47.9% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 59 | 1,620 | $42,120 | $15,894 | 37.7% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 74 | 5,306 | $58,366 | $15,066 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 147 | $31,164 | $13,683 | 43.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $22,720 | $8,192 | 36.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 49 | 1,011 | $27,297 | $7,793 | 28.5% |
| 95044 | Test for allergy using skin patch | Office | 2023 | 18 | 1,186 | $15,418 | $4,176 | 27.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 372 | $14,880 | $3,680 | 24.7% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 24 | 399 | $9,576 | $2,899 | 30.3% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 27 | 390 | $6,240 | $2,309 | 37.0% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 17 | 19 | $1,425 | $546.47 | 38.3% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 28 | 31 | $1,116 | $414.41 | 37.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 11 | 11 | $1,177 | $288.30 | 24.5% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 18 | 8,803 | $553,770 | $261,686 | 47.3% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 55 | 3,926 | $43,186 | $11,747 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 118 | $25,016 | $11,161 | 44.6% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 50 | 960 | $23,280 | $9,428 | 40.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 63 | 63 | $20,160 | $6,916 | 34.3% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 46 | 819 | $22,113 | $6,084 | 27.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 21 | 392 | $15,680 | $3,994 | 25.5% |
| 95044 | Test for allergy using skin patch | Office | 2022 | 14 | 782 | $10,166 | $2,759 | 27.1% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 20 | 245 | $5,880 | $1,558 | 26.5% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 16 | 229 | $3,664 | $1,440 | 39.3% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 13 | 14 | $1,050 | $407.91 | 38.8% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 20 | 22 | $792.00 | $310.69 | 39.2% |
About Dr. Roopen Patel, MD
Dr. Roopen Patel, MD is a Allergy & Immunology healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528145224.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roopen Patel, MD has received a total of $331,146 in payments from pharmaceutical and medical device companies, with $49,244 received in 2024. These payments were reported across 1,075 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($200,423).
As a Medicare-enrolled provider, Patel has provided services to 1,857 Medicare beneficiaries, totaling 77,370 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Charlotte, NC
- Active Since 11/01/2006
- Last Updated 10/26/2016
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1528145224
Products in Payments
- DUPIXENT (Biological) $97,085
- NO PRODUCT DISCUSSED (Drug) $73,538
- NUCALA (Biological) $42,652
- DUPIXENT DUPILUMAB INJECTION (Biological) $29,138
- DUPIXENT (Drug) $27,010
- ATOPIC DERMATITIS - DISEASE (Drug) $19,405
- NIOX VERO DEVICE (Device) $10,007
- TEZSPIRE (Biological) $8,425
- VTAMA (Drug) $1,640
- AREXVY (Drug) $1,046
- Xolair (Biological) $801.96
- FASENRA (Biological) $744.18
- EUCRISA (Drug) $729.62
- FASENRA (Drug) $701.62
- AUVI-Q (Drug) $456.20
- SYMBICORT (Drug) $419.93
- Xhance (Drug) $403.64
- CUTAQUIG (Biological) $351.23
- Hizentra (Biological) $338.80
- TRELEGY ELLIPTA (Drug) $336.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Charlotte
Maeve O'connor, Md, MD
Allergy & Immunology — Payments: $1.8M
Allergy & Immunology $1.8M
Dr. John Norris, Md, MD
Allergy & Immunology — Payments: $208,576
Allergy & Immunology $208,576
Dr. Vandana Patel, M.d, M.D
Allergy & Immunology — Payments: $31,163
Allergy & Immunology $31,163
Richard Collins, Md, MD
Allergy & Immunology — Payments: $26,938
Allergy & Immunology $26,938
Shannon Chadha, Md, MD
Allergy & Immunology — Payments: $24,090
Allergy & Immunology $24,090
Dr. Emily Langley, M.d, M.D
Allergy & Immunology — Payments: $20,585
Allergy & Immunology $20,585